Zhimei C. Lv

China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Corrigendum to: Paraneoplastic glomerulopathy associated with solid tumors: A review, [Crit. Rev. Oncol./Hematol. 227 (2026) 105550].

Corrigendum to: Paraneoplastic glomerulopathy associated with solid tumors: A review, [Crit. Rev. Oncol./Hematol. 227 (2026) 105550].

Journal: Critical reviews in oncology/hematology

Published: September 04, 2026

Paraneoplastic glomerulopathy associated with solid tumors: A review.

Paraneoplastic glomerulopathy associated with solid tumors: A review.

Journal: Critical reviews in oncology/hematology

Published: June 04, 2026

DUSP8 Ameliorates Podocyte Mitochondrial Dysfunction via PRAS40 Dephosphorylation in Diabetic Kidney Disease.

DUSP8 Ameliorates Podocyte Mitochondrial Dysfunction via PRAS40 Dephosphorylation in Diabetic Kidney Disease.

Journal: Free radical biology & medicine

Published: May 26, 2026

Development and validation of a machine learning-based risk prediction model for hyperkalemia in patients with chronic kidney disease.

Development and validation of a machine learning-based risk prediction model for hyperkalemia in patients with chronic kidney disease.

Journal: Scientific reports

Published: April 02, 2026

Role of the post-translational ISGylation of interferon regulatory factor 9 in diabetes-induced podocyte injury.

Role of the post-translational ISGylation of interferon regulatory factor 9 in diabetes-induced podocyte injury.

Journal: Kidney international

Published: December 10, 2025

Lipid metabolism drives podocyte injury in diabetic kidney disease.

Lipid metabolism drives podocyte injury in diabetic kidney disease.

Journal: Frontiers in immunology

Published: December 09, 2025

Molecular mechanisms and therapeutic strategies of glomerular cell senescence in diabetic kidney disease: from heterogeneity to precision intervention.

Molecular mechanisms and therapeutic strategies of glomerular cell senescence in diabetic kidney disease: from heterogeneity to precision intervention.

Journal: Cellular and molecular life sciences : CMLS

Published: November 18, 2025

Histone modification-mediated epigenetic regulation in AKI-to-CKD transition: a cell-type-specific perspective.

Histone modification-mediated epigenetic regulation in AKI-to-CKD transition: a cell-type-specific perspective.

Journal: Journal of translational medicine

Published: August 28, 2025

Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PKCδ/SHP-1-dependent ER stress and relieving podocyte damage and inflammation.

Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PKCδ/SHP-1-dependent ER stress and relieving podocyte damage and inflammation.

Journal: Journal of advanced research

Published: May 03, 2025

LncRNA ENST00000532153.1 alleviates podocyte injury by inhibiting PARP1-mediated PARylation of ATF3 in diabetic kidney disease.

LncRNA ENST00000532153.1 alleviates podocyte injury by inhibiting PARP1-mediated PARylation of ATF3 in diabetic kidney disease.

Journal: Cellular and molecular life sciences : CMLS

Published: April 22, 2025

Glomerular disease associated with cancer: a case series of paraneoplastic nephrotic syndrome.

Glomerular disease associated with cancer: a case series of paraneoplastic nephrotic syndrome.

Journal: Frontiers in medicine

Published: April 10, 2025

Association of rituximab use with adverse events in adults with lymphoma or autoimmune disease: a single center experience.

Association of rituximab use with adverse events in adults with lymphoma or autoimmune disease: a single center experience.

Journal: Frontiers in medicine

Published: February 06, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026